Speech-language pathologists (SLPs) perform evaluations for speech-generating augmentative and alternative communication (AAC) devices. However, many SLPs do not understand what is included in this type of evaluation. In addition, SLPs do not understand when to bill for an evaluation of an ACC device when the evaluation takes more than 1 visit to complete. In this article, I will answer the following questions:

UnitedHealthcare Medicare Advantage has updated their coverage summary for speech generating devices. To access the updated coverage summary for speech generating devices, click

UnitedHealthcare (UHC) Commercial and UHC Oxford have updated their Coverage Determination Guideline for speech generating devices with an effective date of July 1, 2021. To access the updated policy for UHC Commercial, click. To access the updated policy for UHC Oxford, click In addition, UHC Community plan has developed a Coverage Determination Guideline for speech generating devices for the state of Mississippi with an effective date of August 1, 2021. To access this new guideline, click Thank you for being a Gold Member!

UnitedHealthcare Community plan has revised their Speech Generating Devices Coverage Determination Guideline with an effective date of July 1, 2021. To access the revised guideline, click

UnitedHealthcare Medicare Advantage has updated their coverage summary for speech generating devices with an effective date of February 18, 2020. To access the updated clinical policy, click HERE. Thank you for being a Gold Member!